The Global IPV Vaccines Market Analysis
Overview:
There are two vaccines available for polio, one of them is IPV (Inactivated polio vaccine) and another one is known as OPV (Oral Polio Vaccine). IVP is also called as Salk vaccine and is mostly administered on arms or legs. The IPV are safe and help in preventing Poliomyelitis, in children under the age of 5, it can lead to irreversible paralysis and can also result in death. Consumption of IPV is suggested only for these individuals who are undergoing steroid therapy for a long period of time, or is being treated for cancer using chemotherapy. People allergic to streptomycin or eggs are not given injectable IPV. IPV induced immunity does not lasts for a long time period. 90% or more individuals are expected to develop antibodies against three serotypes after taking two doses of inactivated polio vaccine. 99% individuals gained immunity towards polio virus after being injected with inactivated polio vaccine injection.
Global IPV vaccine market’s size was valued at US$ 160 Mn in 2021and it is expected to exhibit a CAGR of 8.5 % and is forecast to reach US$ 240 Mn by 2028.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables& Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-pdf/4965
Impact of COVID-19 Pandemic:
Recent coronavirus outbreak, led to disruption of supply chains, shutting down many distributing and manufacturing units of medical supplies worldwide. Social distancing has been a major cause for the footfall of around 70% health institutions, thus leading to decrease in the number of research and developmental activities, clinical trials and surgical procedures. Hence, hindering the growth of the global IPV vaccines market.
COVID-19 vaccination programs have had a positive effect in eradication the vaccine hesitancy and also increased public awareness in polio endemic countries like Ghana, Nigeria, Gabon, Liberia. Some countries are in need of booster doses of polio vaccines, so they need to implement GPEIs, which will help in reducing the number of polio cases by 90%. The COVID-19 vaccination centers are also used for spreading awareness of polio vaccines.
Drivers:
Increasing government support and increase in immunization programs is expected to boost growth of the global IPV vaccines market during the forecast period. Adoption of new initiatives by major key players for launching and developing inactive polio vaccines is expected to fuel growth of the global IPV vaccines market during the forecast period. Rise in demand for inactive polio vaccines is also expected to drive the growth of the inactive polio vaccines.
Acquire Sample Report + All Related Tables & Graphs, Study Now @ https://www.coherentmarketinsights.com/insight/request-sample/4965
Restraint:
Inactivated polio vaccines can be used for preventing polio in children and adults, this can lead to side effects like itching and rashes. Several studies have proven inactivated polio vaccines to be less effective. For instance, immunization with IPV weakens the immune system and every vaccinated person gets infected with wild poliovirus, later on it reproduces in the intestine. These side effects can cause a negative impact on the community regarding the acceptance of this vaccine, in turn hampering with the growth of the global inactivated polio vaccines market during the forecast period.
Inactivated polio vaccine is more expensive as compared to the oral polio vaccines and this is expected to hinder the growth of the global inactivated polio vaccines market during the forecast period. For instance, in 2019, the WHO (World Health Organization) stated that the IPV vaccines costs US$ 2.8 per dose, whereas OPV costs US$ 0.12 to 0.17 per dose in PAHO nations.
Market Taxonomy:
- By Vaccine Brand:
- Poliovac (Pfs/Sd)
- Shanipv
- Poliorix
- Ipol/Imovax
- Polymilex
- By Distribution Channel:
- Private
- Public
- By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Key Players:
Key players active in the Global IPV vaccines market are Serum Institute of India Pvt. Ltd, PT Bio Farma, AJ Vaccines, AJ Vaccines and GlaxoSmithKline Plc.
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/4965
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Vaccine Brand
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- IPV Vaccine Country wise Adoption Status
- IPV Vaccines Supplied by UNICEF for Gavi
- Polio Vaccination Entry and Exit Requirements
- Contribution of Regulated Markets (U.S., EU5, and Others)
- Market Trends
- Regulatory Scenario
- Pipeline Analysis
- Acquisitions
- PEST Analysis
- Public and Private Pricing – IPV Vaccine
- Epidemiology
- Market Dynamics
- Global IPV Vaccines Market – Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact of COVID-19 on Healthcare market
- COVID-19 Epidemiology
- Global IPV Vaccines Market, By Vaccine Brand, 2021 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Poliovac (PFS/SD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Shanipv
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Poliorix
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Ipol/Imovax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Polymilex
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global IPV Vaccines Market, By Distribution Channel, 2021 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/ipv-vaccines-market-4238
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837